Tiffany M. Delhomme

Lyon, 69372, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Journal: Molecular cancer

Published: February 27, 2026

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer.

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 18, 2023

Proton and alpha radiation-induced mutational profiles in human cells.

Proton and alpha radiation-induced mutational profiles in human cells.

Journal: Scientific reports

Published: October 10, 2022

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.

Journal: Nature genetics

Published: December 25, 2021

TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation.

TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation.

Journal: International journal of molecular sciences

Published: April 07, 2021

The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.

The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.

Journal: Cancers

Published: March 10, 2021

Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer.

Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer.

Journal: Cancers

Published: October 23, 2020

Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.

Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.

Journal: EBioMedicine

Published: December 05, 2019

Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA.

Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA.

Journal: EBioMedicine

Published: July 19, 2019

Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data.

Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data.

Journal: NAR genomics and bioinformatics

Published: June 06, 2019

Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer.

Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer.

Journal: EBioMedicine

Published: April 18, 2019

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.

Journal: Nature communications

Published: November 07, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026